Related references
Note: Only part of the references are listed.Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa
Kim C. E. Sigaloff et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa
Matthew P. Fox et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries
Mar Pujades-Rodriguez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy
Mina C. Hosseinipour et al.
AIDS (2009)
HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
Wouter F. W. Bierman et al.
AIDS (2009)
Incidence and Predictors of Death, Retention, and Switch to Second-Line Regimens in Antiretroviral-Treated Patients in Sub-Saharan African Sites with Comprehensive Monitoring Availability
Leonardo Palombi et al.
CLINICAL INFECTIOUS DISEASES (2009)
Second-line antiretroviral therapy in resource-limited settings:: the experience of Medecins Sans Frontieres
Mar Pujades-Rodriguez et al.
AIDS (2008)
Web resources for HIV type 1 genotypic-resistance test interpretation
TF Liu et al.
CLINICAL INFECTIOUS DISEASES (2006)
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection
S Walmsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
